Tetrabenazine
CAS No : 58-46-8
General description:
Tetrabenazine is an active pharmaceutical ingredient (API) used in the management of hyperkinetic movement disorders, including chorea associated with Huntington’s disease. It functions as a reversible inhibitor of vesicular monoamine transporter 2 (VMAT2), leading to reduced uptake of monoamines into synaptic vesicles and modulation of neurotransmitter release in the central nervous system.
Tetrabenazine is manufactured under stringent quality and regulatory standards to ensure high purity, consistent potency, and reliable performance. It is suitable for formulation development, clinical research, and commercial pharmaceutical manufacturing, supporting the production of effective therapies for movement disorder management.
Tetrabenazine is manufactured under stringent quality and regulatory standards to ensure high purity, consistent potency, and reliable performance. It is suitable for formulation development, clinical research, and commercial pharmaceutical manufacturing, supporting the production of effective therapies for movement disorder management.
Chemical Structure:
